In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 720-726

  Jones, Ronald N ^a   Johnson, David M ^a   Erwin, Meridith E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CLINAFLOXACIN; CLINDAMYCIN; EPEREZOLID; ERYTHROMYCIN; LINEZOLID; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS; CORYNEBACTERIUM; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0029912276     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.720     Document Type: Article

References (15)

1. Brickner, S. J., D. K. Hutchinson, M. R. Barbachyn, S. A. Garmon, K. C. Grega, S. K. Hendges, P. R. Manninen, D. S. Toops, D. A. Ulanowicz, J. O. Kilburn, S. Glickman, G. E. Zurenko, and C. W. Ford. 1995. Synthesis of U-100592 and U-100766, two new oxazolidmone antibacterial agents in clinical trials for treatment of multiply resistant gram positive infections, abstr. 208 In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
2. Brickner, S. J., P. R. Manninen, D. A. Ulanowicz, G. E. Zurenko, R. D. Schaadt, B. H. Yagi, and D. K. Lovasz. 1993. Synthesis and antimicrobial activity of novel multicyclic fused-ring oxazolidinones, abstr. 72. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington, D C
3. Brumfitt, W., and J. M. T. Hamilton-Miller. 1988. In vitro microbiological activities of DuP 105 and DuP 721, novel synthetic oxazolidinones. J Antimicrob Chemother. 21:711-720.
4. Daly, J. S., G. M. Eliopoulos, E. Reiszner, and R. C. Moellering, Jr. 1988 Mechanism of action and in vitro studies of DuP 105 and DuP 721, new oxazolidinone antibacterials. J. Antimicrob. Chemother. 21:721-730.
5. Eustice, D. C., P. A. Feldman, I. Zajac, and A. M. Slee. 1988. Mechanism of action of DuP 721. initiation of an early event during initiation of protein synthesis Antimicrob Agents Chemother. 32:1218-1222
6. Jones, R. N., H. S. Sader, M. E. Erwin, S. C. Anderson, and the Enterococcus Study Group. 1995. Emerging multiply resistant enterococci among clinical isolates. I Prevalence data from 97 medical center surveillance study in the United States. Diagn. Microbiol. Infect. Dis. 21:85-93.
7. Kilburn, J., S. Glickman, S. Brickner, P. Manninen, D. Ulanowicz, K. Lovasz, and G. Zurenko. 1993. In vitro antimycobacterial activity of novel multicyclic fused-ring oxazolidinones, abstr. 73. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. National Committee for Clinical Laboratory Standards. 1993 Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
9. National Committee for Clinical Laboratory Standards. 1993 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. National Committee for Clinical Laboratory Standards. 1993 Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M11-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
11. National Committee for Clinical Laboratory Standards. 1994. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M23-A. National Committee for Clinical Laboratory Standards, Villanova, Pa.
12. Pawsey, S. D., J. D. Harry, and D. J. Stalker. 1995 First administration of a new oxazolidinone antibiotic (U-100592) to man, abstr. F225. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, D.C.
13. Peters, J., K. L. Kondo, R. K. Lee, C. K. Lin, and C. B. Inderlied. 1995 In vitro activity of oxazolidinones against Mycobacterium avium complex. J. Antimicrob. Chemother. 35:675-679.
14. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, P. T. Bartholomew, W. A. Gregory, and M. Forbes. 1987. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721. Antimicrob. Agents Chemother 31:1791-1797.
15. Zajac, I., G. N. Lam, H. E. Hoffman, and A. M. Slee. 1987 Pharmacokinetics of DuP 721, a new synthetic oxazolidinone antibacterial, abstr. 247. In Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.